Breaking News Instant updates and real-time market news.

VIA

Viacom

$35.30

-0.45 (-1.26%)

, FOXA

21st Century Fox

$36.36

0.22 (0.61%)

12:16
04/06/18
04/06
12:16
04/06/18
12:16

Box Office Battle: 'A Quiet Place' looks to overtake 'Ready Player One'

Opening this weekend, and expected to top the box office, is Viacom (VIA, VIAB) subsidiary Paramount's horror thriller "A Quiet Place," directed by John Krasinski, and starring Krasinski and Emily Blunt. The film, which has already earned $4.3M in Thursday night previews, is expected to open domestically in the $33M-38M range. Expected to finish in second place is last weekend's winner, Time Warner's (TWX) subsidiary Warner Bros. sci-fi action flick "Ready Player One." The Stephen Spielberg-directed book adaptation is expected to earn just over $20M in its second weekend at theaters. Also opening this weekend, and expected to fight "Ready Player One" for that second spot, is Comcast (CMCSA, CMCSK) subsidiary Universal's R-rated comedy "Blockers," starring John Cena and Leslie Mann, which is expected to open in the $19M-$20M range. "Tyler Perry's Acrimony," from Lionsgate (LGF.A, LGF.B), is expected to bring in just over $7M in its second weekend at theaters, while Disney's (DIS) "Black Panther" is also expected to bring in around $7M this weekend, its eighth in theaters. Other publicly traded companies in filmmaking include 21st Century Fox (FOX, FOXA) and Sony (SNE).

VIA

Viacom

$35.30

-0.45 (-1.26%)

FOXA

21st Century Fox

$36.36

0.22 (0.61%)

LGF.B

Lionsgate

$24.18

-0.0801 (-0.33%)

VIAB

Viacom

$30.77

0.2 (0.65%)

CMCSA

Comcast

$34.60

0.29 (0.85%)

CMCSK

Comcast

$58.00

(0.00%)

LGF.A

Lionsgate

$25.81

-0.18 (-0.69%)

TWX

Acquired by T

$96.37

-0.02 (-0.02%)

DIS

Disney

$101.05

-1.06 (-1.04%)

SNE

Sony

$48.76

-0.39 (-0.79%)

FOX

21st Century Fox

$36.00

0.33 (0.93%)

  • 08

    Apr

  • 24

    Apr

  • 25

    Apr

  • 08

    May

VIA Viacom
$35.30

-0.45 (-1.26%)

03/28/18
SBSH
03/28/18
UPGRADE
Target $30
SBSH
Neutral
Viacom upgraded to Neutral from Sell at Citi
Citi analyst Jason Bazinet upgraded Viacom (VIAB) to Neutral and raised his price target for the shares to $30 from $26. The analyst assigns a 50% probability of a merger with CBS (CBS) and believes Viacom shares would be worth $30 under such a scenario.
02/28/18
02/28/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Viacom (VIA, VIAB) upgraded to Neutral from Underperform at Macquarie by analyst Tim Nollen, who told investors that the company has taken a decisive turn in strategy to re-set its distribution relationships and is in the early stages of a turnaround. Nollen believes Viacom can return to growth despite any merger outcome with CBS (CBS) and raised estimates on increased U.S. ad and affiliate revenue growth. 2. Tenet (THC) upgraded to Outperform from Market Perform at Raymond James by analyst John Ransom to reflect management's efforts to reduce costs and sell assets. Ransom said the company is reducing debt and could generate $400M in annual free cash flow until its NOL runs out. 3. AB InBev (BUD) upgraded to Positive from Neutral at Susquehanna by analyst Pablo Zuanic, who said the recent weakness provided an attractive entry point as the company had a great January to September period of organic growth, he sees deal synergies with SAB, and he believes Q4 was just as good if not better than the same period a year ago. 4. Etsy (ETSY) upgraded to Buy at Roth Capital by analyst Darren Aftahi after a "strong" Q4 and citing growth reacceleration and margin expansion. 5. Verizon (VZ) upgraded to Buy from Neutral at MoffettNathanson. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/16/18
BNCH
02/16/18
NO CHANGE
Target $86
BNCH
Buy
CBS price target raised to $86 from $78 at Benchmark
Benchmark analyst Daniel Kurnos raised his FY18 revenue forecast for CBS (CBS) by $750M to $14.9B after the company's Q4 report to reflect a healthier ad environment and increased his price target to $86 from $78. While "everyone continues to denigrate" a Viacom (VIAB) merger, Kurnos point outs the international distribution benefits that don't seem to be factored into the equation. The analyst, who thinks CBS shares are "a bargain," keeps a Buy rating on the stock.
02/12/18
BRRR
02/12/18
NO CHANGE
BRRR
Potential reunion with CBS looms over Viacom fundamentals, says Barrington
Barrington analyst James Goss noted that Viacom (VIAB), which reported Q1 earnings last Thursday, beat the firm's EPS estimate, but fell 4% short of its revenue estimate, mainly due to a larger-than-expected decline in the revenue rate for Paramount. Godd reiterated a Market Perform rating on Viacom, saying that while the company's strategy will push it in a favorable direction, in the near term the primary catalyst appears to be the chance to recombine with CBS (CBS).
FOXA 21st Century Fox
$36.36

0.22 (0.61%)

03/07/18
WELS
03/07/18
NO CHANGE
WELS
Wells Fargo expects bidding war for Sky
Wells Fargo analyst Marci Ryvicker expects a bidding war for Sky (SKYAY). The analyst believes Sky appears to be more accretive to Disney (DIS)-Fox (FOXA) but more strategic for Comcast (CMCSA; CMCSK). Ultimately, Ryvicker thinks the latter with win but not without a fight from Disney/Fox.
03/14/18
MACQ
03/14/18
UPGRADE
MACQ
Outperform
Sky upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Guy Peddy upgraded Sky (SKYAY) to Outperform from Neutral after he raised his FY19/20 and FY20/21 EPS by about 16% due to the lower EPL costs. His valuation analysis suggests the current 1075p offer from 21st Century Fox (FOXA) "materially undervalues" Sky and even Comcast's (CMCSA) indicative offer at 1250p "fractionally undervalues" it, Peddy tells investors. What happens next is up to Comcast and Disney (DIS), as Fox is just an intermediary, he added. Peddy raised his price target on Sky shares to 1450p, as he believes tension between those two could lift the offer price at least 10% above his fair value estimate of 1287p.
03/15/18
LOOP
03/15/18
INITIATION
Target $43
LOOP
Buy
21st Century Fox initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started 21st Century Fox (FOXA) with a Buy rating and $43 price target. The analyst believes the company is set up as the "ideal acquisition target for either Disney (DIS) or Comcast (CMCSA) as they evolve their video businesses into a global, direct-to-consumer streaming service."
03/15/18
LOOP
03/15/18
INITIATION
Target $130
LOOP
Buy
Disney initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started Disney (DIS) with a Buy rating and $130 price target. The analyst views the Disney/21st Century Fox (FOXA) deal as a "win/win," positioning Disney to be a more competitive player in the global streaming business.
LGF.B Lionsgate
$24.18

-0.0801 (-0.33%)

02/21/18
02/21/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Capital One (COF) downgraded to Neutral from Buy at Nomura Instinet with analyst Bill Carcache saying he believes the benefit of improving credit is now fully discounted in the shares and he sees "little room" for positive earnings revisions given the company's slowing sales growth. 2. Lionsgate (LGF.A, LGF.B) downgraded to Market Perform from Outperform at Bernstein with analyst Todd Juenger saying he believes competitive investment from rival premium and SVOD services has gotten much more intense, and notes that increased programming investment at Starz is a necessary but recurring cost of doing business, which means the normalized growth rate for Starz has to be lower. 3. Match Group (MTCH) downgraded to Neutral from Overweight at JPMorgan with analyst Doug Anmuth saying he sees fewer catalysts in the first half of 2018 now that the surge in Tinder Gold has passed. 4. BHP Billiton (BHP) downgraded to Neutral from Buy at Citi with analyst Heath Jansen saying the company's first half of fiscal 2018 results were below expectations. 5. Regeneron (REGN) downgraded to Hold from Buy at Canaccord with analyst John Newman citing concern over the company's decision to not provide guidance for Eylea, which is concerning because it will remain the company's core revenue component for many years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/21/18
LOOP
03/21/18
NO CHANGE
Target $36
LOOP
Buy
Lionsgate shares offer attractive entry at current levels, says Loop Capital
After hosting a dinner with CFO James Barge, Loop Capital analyst Alan Gould continues to believe Lionsgate Entertainment is well positioned "operating in the sweet spot" of the media industry and content creation. The company offers an "attractive asset" in a consolidating industry environment, Gould tells investors in a research note. The analyst thinks lower expectations have created an attractive entry price. He keeps a Buy rating on Lionsgate with a $36 price target.
03/15/18
LOOP
03/15/18
INITIATION
Target $36
LOOP
Buy
Lionsgate initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started Lionsgate (LGF.B) with a Buy rating and $36 price target. The company operates in the "sweet spot" of the media industry, content creation, and is not as impacted by advertising or cord cutting, the analyst contends. The analyst views the recent pullback in the shares as a buying opportunity.
03/12/18
RBCM
03/12/18
NO CHANGE
RBCM
Netflix growth and pricing power persist, says RBC Capital
RBC Capital analyst Steven Cahall writes that Netflix is a "gold standard" in content value for consumer, resolving its subscriber issues that alarmed investors just over a year ago. Cahall contends that the company still has growth potential, with estimated 99M Pay TV U.S. household market vs. the company's current 55M U.S. subscriber count. The analyst also points to the "pricing power" of Netflix relative to the competition, stating that the U.S. user engagement of about 124 minutes per day is greater than any other standalone platform and amounts to about $0.003 per watched minute compared to Premium Networks like HBO, Showtime, and Starz are "500%-800% more expensive to watch on a per-minute basis". Moreover, Cahall believes the company is proving itself in the international markets category, where it generated its first positive annual contribution margin in 2017. The analyst estimates that Netflix could have up to $20 in EPS power in the next 5 years, with its stock price rising to as high as $600 per share under a 20-30-times PE valuation.
VIAB Viacom
$30.77

0.2 (0.65%)

04/03/18
KEYB
04/03/18
NO CHANGE
KEYB
Sector Weight
KeyBanc would likely view Viacom acquisition by CBS favorably
KeyBanc analyst Andy Hargreaves notes that news reports suggest an all-stock offer for Viacom (VIAB) by CBS (CBS) is imminent. The analyst believes this would create earnings growth potential through cost synergies in excess of what CBS standalone is capable of and could increase the likelihood of monetizing Viacom-owned assets through disposition. Hargreaves views the near-term risk/reward on CBS as positive and would likely view a deal favorably. He reiterates a Sector Weight rating on CBS shares.
03/28/18
SBSH
03/28/18
NO CHANGE
SBSH
Citi sees 50/50 chance of CBS, Viacom merger
Amid media reports that CBS (CBS) and Viacom (VIAB) are discussing a combination, Citi analyst Jason Bazinet is out with a research note ascribing a 50/50 chance of a deal being reached. The analyst sees three unknowns: will they merge, will CBS pay a premium for Viacom, and how large are the synergies? To reflect the potential for a deal, Bazinet upgraded Viacom to Neutral from Sell and raised his price target for the shares to $30 from $26. The analyst also lowered his price target for Buy-rated CBS to $61 from $71.
04/03/18
LOOP
04/03/18
NO CHANGE
Target $75
LOOP
Buy
CBS take-under offer for Viacom may 'uncouple' the stocks, says Loop Capital
Loop Capital analyst Alan Gould is keeping his Buy rating and $75 price target on CBS (CBS) following yesterday's afterhours reports of a take-under consideration for Viacom (VIAB). The analyst notes that the two stocks have been linked in underperformance, and that the low offer may uncouple that momentum. Gould adds that the deal could give CBS greater scale, allow an opportunity to buy the company early in its turnaround process, and add to its distribution leverage with scale and synergies.
CMCSA Comcast
$34.60

0.29 (0.85%)

03/26/18
COWN
03/26/18
INITIATION
COWN
Market Perform
Comcast initiated with a Market Perform at Cowen
04/02/18
MACQ
04/02/18
NO CHANGE
Target $38
MACQ
Neutral
Macquarie sees Q1 video losses for Comcast
Macquarie analyst Amy Yong is modeling Comcast Q1 video net losses of 77k and revenue declines of .7% due to lower video net adds/ARPU. Yong expects downward estimate revisions for Comcast given headwinds to the video business and uncertainty around its interest in Sky and lowered her 2018/19 consolidated EBITDA to $29.2B and $31.2B, respectively. The analyst rates shares of Comcast a Neutral and cut her price target to $38 from $42.
CMCSK Comcast
$58.00

(0.00%)

02/27/18
RBCM
02/27/18
NO CHANGE
RBCM
RBC says 21st Century Fox may let Comcast go ahead without counter-bid for Sky
After Comcast (CMCSA) proposed a cash offer for Sky (SKYAY) at a 16% premium to 21st Century Fox's (FOX) existing takeover bid, RBC Capital analyst Steven Cahall said that while he does not "profess to know the minds of the Murdochs" on the matter, he is inclined to think that Fox may let Comcast go ahead with its bid as the deal will no longer be "financially opportunistic" as it would have been. Adding that he was surprised Disney's (DIS) original deal for Fox included the Sky stake, Cahall said he's also "inclined to say" that Disney management "can live without Sky" and that the story is "unchanged, and arguably cleaner," without Sky. The analyst, who contends that Disney and Fox are best off letting Comcast "swoop in on Sky," has a Top Pick rating on Disney and an Outperform rating on 21st Century Fox.
02/28/18
02/28/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Celgene (CELG) downgraded to Hold from Buy at SunTrust by analyst Yatin Suneja after the company received a refusal to file letter from the FDA on ozanimod for relapsing forms of multiple sclerosis. Suneja said that following pipeline setbacks in late 2017, ozanimod was central to his "bull thesis to re-accelerate growth" and provide "much needed diversification away from myeloma." Given the delay, he lowered his ozanimod peak sales estimate to $3.5B from $5B. The refusal to file letter could result in a 24-month or longer delay for ozanimod's launch in relapsing forms of multiple sclerosis, Suneja said. 2. Frontier Communications (FTR) downgraded to Hold from Buy at Jefferies by analyst Scott Goldman. With the dividend now suspended and EBITDA stabilization "still a work in progress," the shares have no near-term catalyst, Goldman said. He believes "significant challenges" remain for Frontier following the dividend suspension. 3. Comcast (CMCSA, CMCSK) downgraded to Neutral from Outperform at Macquarie by analyst Amy Young, who cited uncertainty around the M&A playbook and increased net leverage. Young said Comcast's intention to acquire Sky (SKYAY) diversifies its portfolio and increases international revenues to 25% of total from 9% currently, but exposes it to satellite TV, which faces secular pressures. The analyst views the 12x price tag for Sky as high, questions the synergies, and believes the unpredictability could cap near-term upside. 4. e.l.f. Beauty (ELF) downgraded to Market Perform from Outperform at BMO Capital by analyst Shannon Coyne, who cited the "near-term challenges in the mass category" and heightened competition yielding further pressure on results and the stock in the near term. The analyst also points to the management having lowered its expectations for the 3rd time in 6 months, adding that it may take some time for investor confidence to return. Despite the downgrade, the analyst believes that e.l.f "has material white space in existing and new retailers" as well as an "unmatched strong value proposition." 5. Maxim Integrated (MXIM) downgraded to Neutral from Outperform at Macquarie by analyst Srini Pajjuri, who said shares have significantly outperformed the SOX index year-to-date and believes healthy fundamentals are now backed in, combined with some M&A premium. Pajjuri believes further upside is limited on a fundamental basis and believes comps will get tougher in the second half of 2018 and sees risk of higher volatility in Consumer as Samsung GS9 builds fade. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LGF.A Lionsgate
$25.81

-0.18 (-0.69%)

02/21/18
02/21/18
DOWNGRADE
Target $30

Market Perform
Lionsgate downgraded to Market Perform at Bernstein
As previously reported, Bernstein analyst Todd Juenger downgraded Lionsgate to Market Perform from Outperform and cut his price target on the shares to $30 from $35. The analyst believes competitive investment from rival premium and SVOD services has gotten much more intense, and notes that increased programming investment at Starz is a necessary but recurring cost of doing business, which means the normalized growth rate for Starz has to be lower.
TWX Acquired by T
$96.37

-0.02 (-0.02%)

03/15/18
LOOP
03/15/18
INITIATION
Target $107.5
LOOP
Buy
Time Warner initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started Time Warner (TWX) with a Buy rating and $107.50 price target. The analyst believes acquisition by AT&T (T) will go through and that Time Warner shareholders will receive the $107.50 per share, a 12% return over the next two months. If the deal does not go through, Gould believes there is limited downside risk in Time Warner and thinks other interested parties would emerge.
03/19/18
JEFF
03/19/18
UPGRADE
Target $82
JEFF
Buy
Amdocs upgraded to Buy from Hold at Jefferies
Jefferies analyst Ramsey El-Assal upgraded Amdocs (DOX) to Buy and raised his price target for the shares to $82 from $70. Past mergers suggest that the AT&T (T) spend slowdown related to its acquisition of Time Warner (TWX) is only temporary, El-Assal tells investors in a research note. He believes a recovery is "on the horizon regardless of whether the merger is approved or not." The analyst sees upside to fiscal 2019 estimates for Amdocs.
03/23/18
WELS
03/23/18
NO CHANGE
Target $40
WELS
Outperform
AT&T price target lowered to $40 from $48 Wells Fargo
Wells Fargo analyst Jennifer Fritzsche lowered her price target for AT&T (T) to $40 from $48 given recent volatility and uncertainty around Time Warner (TWX) path. Nonetheless, the analyst reiterates an Outperform rating on AT&T shares and believes Q1 2018 will represent the second consecutive quarter of positive handset ads for the company.
03/12/18
03/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Time Warner (TWX) upgraded to Buy from Neutral at UBS with analyst John Hodulik saying while he expects the takeover by AT&T (T) to receive regulatory approval, he believes the current environment would make Time Warner's assets "highly attractive" to other media companies and Internet-based competitors were the deal to be blocked. 2. Carlyle Group (CG) and Apollo Global (APO) were upgraded to Buy from Neutral at Citi. 3. Merck (MRK) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying Keytruda will continue to dominate the first-line non-small cell lung cancer market. 4. SAP (SAP) upgraded to Outperform from In Line at Evercore ISI with analyst Stewart Materne III saying that he believes the risk/reward is more attractive at current levels following the stock's 6% pullback. 5. Aratana Therapeutics (PETX) upgraded to Buy on valuation at CL King with the firm citing favorable risk/reward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DIS Disney
$101.05

-1.06 (-1.04%)

03/09/18
BTIG
03/09/18
NO CHANGE
BTIG
Disney able, but unwilling, to go 'all-in' to win streaming war, says BTIG
BTIG analyst Richard Greenfield believes Disney (DIS) has the content and balance sheet strength to "win" the streaming wars against Netflix (NFLX) and others if it were willing to go "all-in" on digital, but the company appears unwilling to do so. By "all-in," Greenfield says he means making every new theatrical release from Disney available on their streaming service day and date with its theatrical release. Such an aggressive strategy would be how Disney could 'win the streaming wars, rather than dipping their toe in the water of streaming while trying to "milk" their legacy business models,' Greenfield contends in a new note to investors.
SNE Sony
$48.76

-0.39 (-0.79%)

01/23/18
JPMS
01/23/18
DOWNGRADE
JPMS
Neutral
Sony downgraded to Neutral from Overweight at JPMorgan
01/23/18
01/23/18
DOWNGRADE

Neutral
Sony downgraded to Neutral on slowing dual-cam adoption at JPMorgan
As previously reported, JPMorgan downgraded Sony (SNE) to Neutral from Overweight, citing slowing adoption of dual-cams. The firm notes that reports indicate Apple's (AAPL) iPhone 6.05" LCD model will not have a dual-cam feature, which it sees presenting a material downside risk in dual-camera adoption in the second half of 2018.
12/07/17
BARD
12/07/17
NO CHANGE
BARD
Data so far suggesting healthy holiday game sales, says Baird
Baird analyst Colin Sebastian noted that French game maker Ubisoft (UBSFY) raised its revenue and margin guidance for the December quarter, which he views as a slight positive for video game industry sales momentum this holiday season. Data also point to solid sales for both Sony's (SNE) PS4 and Nintendo's (NTDOY) Switch, which are a driver of software as well as a key catalyst for Gamestop (GME), Sebastian added. Other publicly traded companies in the video game space include Activision Blizzard (ATVI), Electronic Arts (EA), Take-Two (TTWO) and Microsoft (MSFT).
11/17/17
RILY
11/17/17
NO CHANGE
Target $36
RILY
Neutral
21st Century Fox price target raised to $36 from $29 at B. Riley FBR
B. Riley FBR analyst Barton Crockett raised his price target for 21st Century Fox (FOXA) to $36 citing recent reports that Disney (DIS), Comcast (CMCSA), Verizon (VZ) or Sony (SNE) may make offers for the company. The "formerly unthinkable" prospect of Rupert Murdoch selling assets is likely to be factored into the equity price for some time, Crockett tells investors in a research. He keeps a Neutral rating on Fox given the stock's proximity to his new target.
FOX 21st Century Fox
$36.00

0.33 (0.93%)

01/28/18
PIPR
01/28/18
NO CHANGE
PIPR
Growth of sports rights may be coming down, says Piper Jaffray
Piper Jaffray analyst Stan Meyers says he is starting to see some evidence that the growth of sports rights may be coming down toward a more reasonable rate. The analyst notes that only CBS (CBS), Fox (FOXA) and NBC (CMCSK; CMCSA) submitted bids for Thursday Night Football rights, with CBS and NBC submitting bids below their current rate of $450M per year, and Fox making a higher bid for the rights, in a likely effort to establish itself as a "live sports and news" network in the wake of selling a majority of assets to Disney (DIS). On the digital side, Facebook (FB) declined to make an offer for digital streaming rights to TNF, while Amazon (AMZN), which paid $50M this year, and Twitter (TWTR), which paid $10M last year did submit bids.

TODAY'S FREE FLY STORIES

QLYS

Qualys

$69.24

-5.355 (-7.18%)

06:41
11/20/18
11/20
06:41
11/20/18
06:41
Upgrade
Qualys rating change  »

Qualys upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Jan

JD

JD.com

$21.09

-1.95 (-8.46%)

06:38
11/20/18
11/20
06:38
11/20/18
06:38
Downgrade
JD.com rating change  »

JD.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$21.09

-1.95 (-8.46%)

06:35
11/20/18
11/20
06:35
11/20/18
06:35
Periodicals
JD.com CEO says focus will be on strategy, new businesses, Yicai reports »

JD.com founder and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRL

Hormel Foods

$45.36

-0.535 (-1.17%)

06:35
11/20/18
11/20
06:35
11/20/18
06:35
Earnings
Breaking Earnings news story on Hormel Foods »

Hormel Foods sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TGT

Target

$77.13

-1.9 (-2.40%)

06:34
11/20/18
11/20
06:34
11/20/18
06:34
Earnings
Breaking Earnings news story on Target »

Target sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

TGT

Target

$77.13

-1.9 (-2.40%)

06:34
11/20/18
11/20
06:34
11/20/18
06:34
Hot Stocks
Breaking Hot Stocks news story on Target »

Target sees Q4 SSS up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

MMS

Maximus

$63.91

-2.05 (-3.11%)

06:33
11/20/18
11/20
06:33
11/20/18
06:33
Earnings
Maximus sees FY19 revenue $2.95B-$3.0B, consensus $2.53B »

Sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TGT

Target

$77.13

-1.9 (-2.40%)

06:33
11/20/18
11/20
06:33
11/20/18
06:33
Earnings
Target reports Q3 adj. EPS $1.09, consensus $1.12 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

HRL

Hormel Foods

$45.36

-0.535 (-1.17%)

06:32
11/20/18
11/20
06:32
11/20/18
06:32
Earnings
Hormel Foods reports Q4 adj. EPS 51c, consensus 49c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MMS

Maximus

$63.91

-2.05 (-3.11%)

06:31
11/20/18
11/20
06:31
11/20/18
06:31
Earnings
Maximus reports Q4 revenue $558.4M, consensus $587.58M »

Reports Q4 EPS 71c vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HSDT

Helius Medical

$8.02

-0.08 (-0.99%)

06:31
11/20/18
11/20
06:31
11/20/18
06:31
Upgrade
Helius Medical rating change  »

Helius Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WWD

Woodward

$79.45

-2.46 (-3.00%)

06:30
11/20/18
11/20
06:30
11/20/18
06:30
Upgrade
Woodward rating change  »

Woodward upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

QEP

QEP Resources

06:27
11/20/18
11/20
06:27
11/20/18
06:27
Upgrade
QEP Resources rating change  »

QEP Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$45.12

-1.48 (-3.18%)

06:27
11/20/18
11/20
06:27
11/20/18
06:27
Downgrade
Western Digital rating change  »

Western Digital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

EQIX

Equinix

, KNX

Knight-Swift

$32.23

0.51 (1.61%)

06:26
11/20/18
11/20
06:26
11/20/18
06:26
Recommendations
Equinix, Knight-Swift analyst commentary  »

Equinix, Knight-Swift…

EQIX

Equinix

KNX

Knight-Swift

$32.23

0.51 (1.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 10

    Dec

DHI

D.R. Horton

$34.98

0.19 (0.55%)

, KSU

Kansas City Southern

$98.99

-1.795 (-1.78%)

06:26
11/20/18
11/20
06:26
11/20/18
06:26
Recommendations
D.R. Horton, Kansas City Southern analyst commentary  »

D.R. Horton, Kansas City…

DHI

D.R. Horton

$34.98

0.19 (0.55%)

KSU

Kansas City Southern

$98.99

-1.795 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 05

    Dec

SWKS

Skyworks

06:25
11/20/18
11/20
06:25
11/20/18
06:25
Downgrade
Skyworks rating change  »

Skyworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$35.26

-1.15 (-3.16%)

06:25
11/20/18
11/20
06:25
11/20/18
06:25
Downgrade
Teradyne rating change  »

Teradyne downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$21.08

-0.75 (-3.44%)

, ACHC

Acadia

$32.05

-0.51 (-1.57%)

06:23
11/20/18
11/20
06:23
11/20/18
06:23
Periodicals
KKR still in talks to buy Acadia Healthcare, NY Post reports »

KKR (KKR) is still deep…

KKR

KKR

$21.08

-0.75 (-3.44%)

ACHC

Acadia

$32.05

-0.51 (-1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$78.54

-0.79 (-1.00%)

, AET

Aetna

$207.68

-1.49 (-0.71%)

06:21
11/20/18
11/20
06:21
11/20/18
06:21
Hot Stocks
CVS Health, Aetna deal expected to close after Thanksgiving holiday »

In connection with the…

CVS

CVS Health

$78.54

-0.79 (-1.00%)

AET

Aetna

$207.68

-1.49 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$32.46

-1.22 (-3.62%)

06:21
11/20/18
11/20
06:21
11/20/18
06:21
Downgrade
Ciena rating change  »

Ciena downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSDT

Helius Medical

06:19
11/20/18
11/20
06:19
11/20/18
06:19
Upgrade
Helius Medical rating change  »

Helius Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QLYS

Qualys

$69.24

-5.355 (-7.18%)

06:19
11/20/18
11/20
06:19
11/20/18
06:19
Upgrade
Qualys rating change  »

Qualys upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Jan

NERV

Minerva

$8.32

-0.09 (-1.07%)

06:17
11/20/18
11/20
06:17
11/20/18
06:17
Conference/Events
Minerva management to host key opinion leader breakfast meeting »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

INGN

Inogen

$137.57

-4.28 (-3.02%)

06:16
11/20/18
11/20
06:16
11/20/18
06:16
Upgrade
Inogen rating change  »

Inogen upgraded to Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.